Cargando…
Alpha7 nAChR Agonists for Cognitive Deficit and Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Double-blind Controlled Trials
BACKGROUND: Previous clinical trials of α7-nicotinic acetylcholine receptor agonists (α7-nAChR agonists) showed mixed results in treating the cognitive and negative symptoms of schizophrenia. AIMS: To assess the efficacy and safety of α7-nAChR agonists in treating the cognitive and negative symptoms...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Shanghai Municipal Bureau of Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608991/ https://www.ncbi.nlm.nih.gov/pubmed/28955138 http://dx.doi.org/10.11919/j.issn.1002-0829.217044 |
Ejemplares similares
-
Efficacy Towards Negative Symptoms and Safety of Repetitive Transcranial Magnetic Stimulation Treatment for Patients with Schizophrenia: A Systematic Review
Publicado: (2017) -
Sulfonium Ligands of the α7 nAChR
por: Horenstein, Nicole A., et al.
Publicado: (2021) -
PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis
por: Zhang, Zhuo-Ya, et al.
Publicado: (2023) -
Effect of the a7nAChR agonist GTS-21 on inflammation during human endotoxemia
por: Pompe, J, et al.
Publicado: (2009) -
Mismatch Negativity in Han Chinese Patients with Schizophrenia: A Meta-Analysis
Publicado: (2017)